You searched for rivaroxaban - MPR

Your search for rivaroxaban returned 23 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Drugs in the Pipeline remove

Your search for rivaroxaban returned 23 results

Sort Results:

Relevant Recent
Drugs in the Pipeline

Phase 3 Study of Xarelto for Treatment and Secondary Prevention of Venous Blood Clots

Janssen Research & Development announced results of the EINSTEIN-PE study showing that Xarelto (rivaroxaban) was comparable to today's standard of care in treating patients with acute symptomatic pulmonary embolism (PE) and in preventing development of a secondary venous blood clot (known as venous thromboembolism or VTE).
Drugs in the Pipeline

First Results of Rivaroxaban for VTE Treatment in Active Cancer

Janssen and Bayer presented the first results from their comprehensive research program, CALLISTO, which evaluated rivaroxaban for the treatment and prevention of venous thromboembolism (VTE) in patients with active cancer, at the 2015 American Society of Hematology (ASH) Annual Meeting.
Drugs in the Pipeline

Xarelto to be Evaluated in 3 New Thromboembolism Trials

Janssen R&D announced the addition of three new clinical trials under the EXPLORER global cardiovascular research program for Xarelto (rivaroxaban) to be evaluated for thromboembolic disorders.